Table 8.
20 mg PGE1 | 2 mg Phentolamine | P | |
---|---|---|---|
PSV | 48 cm/s | 52.6 cm/s | P<0.001 |
EDV | 7.7 cm/s | 1.8 cm/s | P=0.0001 |
Sixteen out of 18 study patients received phentolamine. (PSV, peak systolic velocity measured in cm/s; EDV, end diastolic velocity measured in cm/s)